Translate
Hansa Biopharma Ab
About
Hansa Biopharma Ab (F:24H) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
Hansa Biopharma publishes 2025 Annual and Sustainability Reports
Mar 4 2026
PDUFA Action Date for Hansa Biopharma's Imlifidase BLA Set for December 19, 2026
Feb 18 2026
Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
Feb 11 2026
Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results
Feb 10 2026
KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer